Further digging in ETH Zurich particulate vaccine project led me to this 2018 Phd position from university of Zurich both universities are collaborating in this.
Link to Phd position and quite a nice job description, I think fimavacc/NAC are getting exciting now:
https://www.academicgates.com/job/detail/7912476b-1ba4-46ba-a36a-6c5d0cc87f9b
Aufgabenbereich / Responsibilities
The appointed PhD student will conduct experimental research on all aspects of cancer immunotherapy utilising a novel method called Photochemical internalisation (PCI), which combines vaccination and photodynamic therapy. The work is done in close collaboration with researchers from the Institute of Pharmaceutical Sciences at ETH Zurich who provide help in formulation of particulate vaccines, e.g. liposomes, and a biotech partner. The PhD student will be developing and testing vaccines in tissue cultures and in mice, and she/he will be using immunological and molecular assessment methods in vitro and in vivo, e.g. FACS, ELISA, immunohistochemistry, immunofluorescence microscopy, PCR and WB. The project is supported by the Swiss National Science foundation, University of Zurich, and a biotech partner.
Here they are talking about developing and testing new vaccines !! Exciting
Also they talk about a biotech partner, who do you think this is? Is it Pci biotech or One of our partners in the collaboration agreements? BioNtech for example ??